在高胆固醇血症中,增强的可溶性CD40L和前血栓状况之间的关联:他类药物治疗的影响
Francesco Cipollone1, Andrea Mezzetti, Ettore Porreca
1Center of Excellence on Aging, University of Chieti G. D'Annunzio School of Medicine, Chieti, Italy.
Circulation
|July 24, 2002
概括
高胆固醇与血液凝固问题有关. 可溶性CD40连接体 (sCD40L) 可能将高胆固醇与这种前血栓状况联系起来,而他类药物可以减少这两种情况.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高胆固醇血症与炎症和前血栓状况有关.
- CD40-CD40连接体 (CD40L) 相互作用有助于原血栓反应.
- 在高胆固醇血症中研究可溶性CD40L (sCD40L) 是至关重要的.
研究的目的:
- 在高胆固醇血症中体现体内sCD40L表达的特征.
- 与sCD40L与原血栓状态相关联.
- 评估他类药物对sCD40L和前血栓标记物的影响.
主要方法:
- 该研究包括80名高胆固醇血症患者和80名健康对照.
- 测量了sCD40L,因子VIIa (FVIIa),前热血素片段1+2 (F1+2),P-选择素,以及11-脱-血栓B2.
- 评估了他类药物治疗 (pravastatin,cerivastatin) 对这些标记物的影响.
主要成果:
- 患有高胆固醇血症的受试者显示sCD40L,FVIIa和F1+2.2的升高.
- sCD40L与总胆固醇,LDL胆固醇,血小板激活和前凝性标记物相关联.
- 静止剂治疗显著降低了sCD40L,FVIIa和F1+2水平.
结论:
- sCD40L可能是高胆固醇血症和原血栓状态之间的分子联系.
- 达丁类药物治疗有效降低sCD40L和相关的原血栓标记物.
- 这些发现支持他类药物在管理高胆固醇血相关的血栓形成风险.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Cholesterol: Significance and Regulation
2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.1K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
859
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
859
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747


